Statement from BioNTech on Scary Covid-19 Variant

The world’s test with the Covid-19 epidemic still continues. The epidemic, which has turned into a global crisis for the last two years, has once again caused alarm in Europe. While the increase in the number of cases continues rapidly ‘mandatory vaccination’ also came to the fore. A variant detected in South Africa also worries experts. by the World Health Organization “Omicron” The variant, called so-called variant, is frequently seen in cases in South Africa.

So why are experts worried? According to the data obtained, this new variant is extremely high number of mutations owner. Therefore, experts cannot predict how successful current vaccines will be. detected in South Africa. Omicron variant, with more than thirty-two mutations, can show resistance to existing vaccines. A new statement came from BioNTech company on this subject.

If new vaccines are required, the first doses can be administered within 100 days:

BioNTech, the most preferred vaccine in Europe, will come in a joint statement with Pfizer in two weeks more about the new variant will collect data and based on these data a change in vaccines He said they would decide whether it should be done or not. If a change in vaccines is required, the company “within 6 weeks” be able to design a new vaccine and First doses within 100 days stated that he would be ready for implementation.

One of the questions that comes to mind with this news is: What is the difference between this variant in South Africa and the Delta variant? Delta, most contagious variant of the virus It is currently the most common variant in cases worldwide. However, new Omicron In addition to being contagious, the variant can easily bypass the immune system with its high number of mutations. We expect new statements on this subject from experts in the next two weeks.